Prazosin Hydrochloride

Product NDC: 51079-630
11-digit product format: 510790630
Labeler code: 51079
Product ID: 51079-630_3a874e40-912d-740d-e063-6394a90a4778
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: prazosin hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: Mylan Institutional Inc.
Application: ANDA072575
Marketing category: ANDA
Marketing start: 1998-10-05
Substance: PRAZOSIN HYDROCHLORIDE
Active strength: 1 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51079-630-20	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51079-630-20	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A072575-001	PRAZOSIN HYDROCHLORIDE	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16
A072575-002	PRAZOSIN HYDROCHLORIDE	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16
A072575-003	PRAZOSIN HYDROCHLORIDE	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A072575-001	AB
A072575-002	AB
A072575-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072575-002	PRAZOSIN HYDROCHLORIDE	EQ 2MG BASE	CAPSULE / ORAL	AB	1989-05-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072575-003	PRAZOSIN HYDROCHLORIDE	EQ 1MG BASE	CAPSULE / ORAL	AB	1989-05-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A072575-001	PRAZOSIN HYDROCHLORIDE	EQ 5MG BASE	CAPSULE / ORAL	AB	1989-05-16	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A072575-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A072575-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A072575-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A072575-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A072575-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A072575-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072575-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072575-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A072575-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A072575-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A072575-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A072575-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072575-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072575-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A072575-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072575-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072575-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A072575-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072575-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072575-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A072575-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072575-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072575-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A072575-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072575-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072575-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A072575-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072575-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072575-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A072575-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A072575-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A072575-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A072575-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072575-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072575-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A072575-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072575-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072575-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A072575-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A072575-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: Yes
Brand name base: Prazosin Hydrochloride
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PRAZOSIN HYDROCHLORIDE	1 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X0Z7454B90	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198141	Internal RxNorm lookup
312593	Internal RxNorm lookup
312594	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e6a029b2-802f-4cc5-8795-20e177e8d779	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d5a3de99-75de-4527-38ae-07b1328b93cb	Product name	5	20250331

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51079-630-01	Prazosin Hydrochloride	1 in 1 BLISTER PACK	CAPSULE	1		12
51079-630-20	Prazosin Hydrochloride	100 in 1 CARTON	CAPSULE	100		12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51079-630-01	EA - Each	51079-630	4f069d24-6fef-4f16-8c57-31ddf1f9fa8d	1	2013-02-13
51079-630-20	EA - Each	51079-630	1179b279-47de-4131-bb03-d4de32244df0	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PRAZOSIN HYDROCHLORIDE	ACTIVE INGREDIENT	X0Z7454B90	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
PRAZOSIN	ACTIVE MOIETY	XM03YJ541D	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
FD&C GREEN NO. 3	INACTIVE INGREDIENT	3P3ONR6O1S	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51079-630	PRAZOSIN HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]	11	Current NDC, Legacy NDC, 2 package rows	20241010_e6a029b2-802f-4cc5-8795-20e177e8d779.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	REMEDYREPACK INC.	39e3fa5d-ea48-4b02-80f6-44591f5e013f	2026-07-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	Safecor Health LLC	12cdde5b-173c-4f31-a326-3128d521930c	2026-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	e5e129aa-2ee3-4c12-a327-5d5382cf2310	2025-10-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	5d7dff44-84b1-4044-bc5a-c76ea11dd5a3	2025-10-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	cd52f022-ca29-4f87-8684-da63e05b3c1f	2025-10-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	Mylan Institutional Inc.	e6a029b2-802f-4cc5-8795-20e177e8d779	2025-07-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575 ndc (product): 51079-630
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	Bryant Ranch Prepack	1a92a503-cf5e-48ef-a6fd-79fe98fdd8a0	2023-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575
Prazosin Hydrochloride	PRAZOSIN HYDROCHLORIDE	Mylan Pharmaceuticals Inc.	1ce90aaf-d075-4617-9a47-e8d922096d23	2022-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 072575 application number: ANDA072575

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X0Z7454B90	PRAZOSIN HYDROCHLORIDE	19237-84-4	PRAZOSIN HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312593	prazosin HCl 1 MG Oral Capsule	PSN	e6a029b2-802f-4cc5-8795-20e177e8d779	12
312594	prazosin HCl 2 MG Oral Capsule	PSN	e6a029b2-802f-4cc5-8795-20e177e8d779	12
198141	prazosin HCl 5 MG Oral Capsule	PSN	e6a029b2-802f-4cc5-8795-20e177e8d779	12
312593	prazosin 1 MG Oral Capsule	SCD	e6a029b2-802f-4cc5-8795-20e177e8d779	12
312594	prazosin 2 MG Oral Capsule	SCD	e6a029b2-802f-4cc5-8795-20e177e8d779	12
198141	prazosin 5 MG Oral Capsule	SCD	e6a029b2-802f-4cc5-8795-20e177e8d779	12
312593	prazosin (as prazosin HCl) 1 MG Oral Capsule	SY	e6a029b2-802f-4cc5-8795-20e177e8d779	12
312594	prazosin (as prazosin HCl) 2 MG Oral Capsule	SY	e6a029b2-802f-4cc5-8795-20e177e8d779	12
198141	prazosin (as prazosin HCl) 5 MG Oral Capsule	SY	e6a029b2-802f-4cc5-8795-20e177e8d779	12

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51079-630-01	51079063001	1 in 1 BLISTER PACK						Historical
51079-630-20	51079063020	100 BLISTER PACK in 1 CARTON (51079-630-20) / 1 CAPSULE in 1 BLISTER PACK (51079-630-01)	100 blister pack	1998-10-05	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Prazosin Hydrochloride - Mylan Institutional Inc.	Mylan Institutional Inc.	2025-07-22	HUMAN PRESCRIPTION DRUG LABEL	12
Prazosin Hydrochloride - Cardinal Health	Cardinal Health	2019-07-01	HUMAN PRESCRIPTION DRUG LABEL	6